Collectively, if MSH6 is thoroughly evaluated, this marker may aid in prognostication of endometrial cancer patients preoperatively, thus refining patient stratification for invasive surgery and adjuvant therapy, and in addition function as an MMR-D classifier [12, 31]. The gene discussed is MSH6; the disease is endometrial cancer.